These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 29197335)

  • 1. Trends in prevalence, mortality, health care utilization and health care costs of Swiss IBD patients: a claims data based study of the years 2010, 2012 and 2014.
    Bähler C; Vavricka SR; Schoepfer AM; Brüngger B; Reich O
    BMC Gastroenterol; 2017 Dec; 17(1):138. PubMed ID: 29197335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic comorbidities associated with inflammatory bowel disease: prevalence and impact on healthcare costs in Switzerland.
    Bähler C; Schoepfer AM; Vavricka SR; Brüngger B; Reich O
    Eur J Gastroenterol Hepatol; 2017 Aug; 29(8):916-925. PubMed ID: 28471826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in health-care costs and utilization for inflammatory bowel disease from 2010 to 2014 in Korea: A nationwide population-based study.
    Kim JW; Lee CK; Rhee SY; Oh CH; Shim JJ; Kim HJ
    J Gastroenterol Hepatol; 2018 Apr; 33(4):847-854. PubMed ID: 29055148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic analysis of annual health resource utilization and costs in hospitalized patients with inflammatory bowel disease in Switzerland.
    Schoepfer A; Vavricka SR; Brüngger B; Reich O; Blozik E; Bähler C
    Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):868-875. PubMed ID: 29757772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct health-care cost utilization in Hong Kong inflammatory bowel disease patients in the initial 2 years following diagnosis.
    Mak LY; Ng SC; Wong IOL; Li MKK; Lo FH; Wong MTL; Leung CM; Tsang SWC; Chan KH; Sze SF; Shan EHS; Lam BCY; Hui AJ; Hung IFN; Leung WK
    J Gastroenterol Hepatol; 2018 Jan; 33(1):141-149. PubMed ID: 28475813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Market share and costs of biologic therapies for inflammatory bowel disease in the USA.
    Yu H; MacIsaac D; Wong JJ; Sellers ZM; Wren AA; Bensen R; Kin C; Park KT
    Aliment Pharmacol Ther; 2018 Feb; 47(3):364-370. PubMed ID: 29164650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Does the hospital cost of care differ for inflammatory bowel disease patients with or without gastrointestinal infections? A case-control study].
    Schmidt C; Köhler F; Kräplin T; Hartmann M; Lerch MM; Stallmach A
    Z Gastroenterol; 2014 Jul; 52(7):643-8. PubMed ID: 25026005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mental Health Costs of Inflammatory Bowel Diseases.
    Szigethy E; Murphy SM; Ehrlich OG; Engel-Nitz NM; Heller CA; Henrichsen K; Lawton R; Meadows P; Allen JI
    Inflamm Bowel Dis; 2021 Jan; 27(1):40-48. PubMed ID: 32095835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Evolution of Health Care Utilisation and Costs for Inflammatory Bowel Disease Over Ten Years.
    Pillai N; Dusheiko M; Maillard MH; Rogler G; Brüngger B; Bähler C; Pittet VEH;
    J Crohns Colitis; 2019 May; 13(6):744-754. PubMed ID: 30916775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healthcare utilization and comorbidity burden among children and young adults in the United States with systemic lupus erythematosus or inflammatory bowel disease.
    Karve S; Candrilli S; Kappelman MD; Tolleson-Rinehart S; Tennis P; Andrews E
    J Pediatr; 2012 Oct; 161(4):662-670.e2. PubMed ID: 22578787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors That Predict High Health Care Utilization and Costs for Patients With Inflammatory Bowel Diseases.
    Limsrivilai J; Stidham RW; Govani SM; Waljee AK; Huang W; Higgins PD
    Clin Gastroenterol Hepatol; 2017 Mar; 15(3):385-392.e2. PubMed ID: 27645518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High end of life health care costs and hospitalization burden in inflammatory bowel disease patients: A population-based study.
    Murthy SK; James PD; Antonova L; Chalifoux M; Tanuseputro P
    PLoS One; 2017; 12(5):e0177211. PubMed ID: 28498877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal Trends in the Direct Costs and Health Care Utilization Ascribable to Inflammatory Bowel Disease in the Biologic Era: Results From a Canadian Population-Based Analysis.
    Targownik LE; Kaplan GG; Witt J; Bernstein CN; Singh H; Tennakoon A; Aviña Zubieta A; Coward SB; Jones J; Kuenzig ME; Murthy SK; Nguyen GC; Peña-Sánchez JN; Benchimol EI
    Am J Gastroenterol; 2020 Jan; 115(1):128-137. PubMed ID: 31895723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health care resource utilization in inflammatory bowel disease.
    Longobardi T; Bernstein CN
    Clin Gastroenterol Hepatol; 2006 Jun; 4(6):731-43. PubMed ID: 16631415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variations in care: a retrospective database analysis of healthcare utilization patterns for patients with inflammatory bowel disease.
    David G; Gunnarsson C; Lofland JH
    J Med Econ; 2015 Feb; 18(2):137-44. PubMed ID: 25335098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shifting Cost-drivers of Health Care Expenditures in Inflammatory Bowel Disease.
    Click B; Lopez R; Arrigain S; Schold J; Regueiro M; Rizk M
    Inflamm Bowel Dis; 2020 Jul; 26(8):1268-1275. PubMed ID: 31671186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiology and socio-economic aspects of chronic inflammatory bowel diseases in Switzerland].
    Schoepfer A; Safroneeva E
    Ther Umsch; 2019 Jan; 75(5):255-259. PubMed ID: 30700239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of aging on healthcare costs of inflammatory bowel disease: a glimpse into the future.
    van der Have M; Mangen MJ; van der Valk ME; Smeets HM; van Bodegraven A; Dijkstra G; Fidder HH; de Jong DJ; Pierik M; Ponsioen CY; van der Meulen-de Jong AE; van der Woude CJ; van de Meeberg PC; Romberg-Camps MJ; Clemens CH; Jansen JM; Mahmmod N; Bolwerk CJ; Vermeijden JR; Siersema PD; Leenders M; Oldenburg B; ;
    Inflamm Bowel Dis; 2014 Apr; 20(4):637-45. PubMed ID: 24518606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased prevalence of and associated mortality with methicillin-resistant Staphylococcus aureus among hospitalized IBD patients.
    Nguyen GC; Patel H; Chong RY
    Am J Gastroenterol; 2010 Feb; 105(2):371-7. PubMed ID: 19809406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Integrated management of patients with chronic inflammatory bowel disease in the Rhine-Main Region: results of the first integrated health-care project IBD in Germany].
    Blumenstein I; Tacke W; Filmann N; Zosel C; Bock H; Heuzeroth V; Zeuzem S; Schröder O
    Z Gastroenterol; 2013 Jul; 51(7):613-8. PubMed ID: 23696113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.